Evaluating the impact of a pre-discharge medication review service on preventing hospital re-admissions in high risk patients-a pilot study.

niversity of Tasmania0 个研究点目标入组 226 人开始时间: 2015年7月20日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•The recruitment of eligible patients will be predicated upon the risk assessment tool as described by Angley and co-workers.
•Patients were stratified as being at ‘high’
•or ‘low’ risk of medication misadventure using a stratification instrument adapted from the Victorian Medication Alert Project and The Alfred Hospital Outreach Medication Review program. Patients who scored more than 5 points were at ‘high’ risk of medication misadventure. They will be invited to join the study or control cohorts.
•The risk weighting per question is outlined in the attached file. Score per question ranges from 1 to 5.
•Angley M, Pooniah A, Bong J., Padhye V, Shakib S, Spurling L. Implementing and evaluating a parallel post-discharge Home Medicines Review (HMR) model: Pharmacy Guild of Australia;

•1. Patients will be excluded if they are to be discharged into an aged care facility (ACF), since each ACF has, under the Medicare provisions, a contracted consultant pharmacist who performs medication reviews within the ACF setting.
•2. Patients will be excluded if they live outside of the Greater Sydney area, interstate (or further).
•3. Patients will be excluded if they are unable agree to a medication review and the follow-up phone contact within the timeframe as set out for this study.
•4. Patients will be excluded if there is an obvious language barrier which cannot be resolved with the aid of a family member.

发起方

niversity of Tasmania